Centene Corporation (CNC) Earnings Call Transcripts

81 earnings calls from January 2020 to September 16, 2026

NYSE US Health Care Health Care Providers and Services

Centene Corporation's Latest Earnings Call - September 16, 2026

In the Q3 2026 earnings call, Centene Corporation (CNC:US) reiterated its full-year adjusted diluted EPS guidance of greater than $4.80, indicating stability in performance despite ongoing challenges in the Medicaid segment. The company reported consistent trends across its business lines, with Medicaid rates aligning with a 5% composite outlook. Management expressed confidence in maintaining margins, particularly in the Medicare and PDP segments, while navigating potential membership declines due to upcoming work requirements and policy changes. Overall, the guidance and performance suggest a steady trajectory for the remainder of the fiscal year, which could positively influence stock performance.

Reported metrics

MetricValueContext
Adjusted Diluted EPS > $4.80 (inline) Reiterated guidance for FY 2026, maintaining previous expectations.
Medicaid Membership Decline 8% to 9% (negative) Projected decline by end of 2026 due to eligibility tightening.
Medicaid Composite Rate Outlook 5% (inline) Consistent with full-year expectations.
PDP Margins > 3% (positive) On track for 2026.
Medicare Margin Target Breakeven or better (positive) Expected for 2027.
Medicaid HBR 93.5% (positive) Target for year, showing margin improvement.

Guidance from management

Centene maintained its adjusted diluted EPS guidance of greater than $4.80 for 2026, while expressing confidence in achieving breakeven or better margins in Medicare for 2027.

What management said

Let me reinforce something that I think the skin already knows, but like the community rating aspect in Medicaid is such that the pool of data is aggregated each state from all the payers. And so there's a relativity. So the program as a whole needs to have some margin. And if you can outperform the average of that pool like we have historically, and we expect to prospectively then that creates a nice opportunity t...
— Andrew Asher, September 16, 2026 earnings call
No. I mean the trends in MA has been very consistent this year. and the places that are sort of, again, slight outside trend drivers, some of that outpatient a little bit of high-cost drug, very consistent, same thing so far in Q3 and continue to feel good about how that business is performing.
— Sarah London, September 16, 2026 earnings call

What analysts pressed on

Analysts expressed concerns regarding the potential impact of membership declines on revenue and margins, particularly in the Medicaid segment. There were questions about how Centene plans to manage the acuity shift and the implications of work requirements on enrollment.

Main topics on the call

Read the full Centene Corporation transcript (September 16, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Centene Corporation

Centene Corporation (CNC) is a publicly listed company in the Health Care Providers and Services industry, within the Health Care sector. It trades on NYSE and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 81 calls on record spanning January 13, 2020 to September 16, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 81 Centene Corporation earnings call transcripts on record, spanning January 13, 2020 to September 16, 2026. Based on this history, Centene Corporation reports quarterly. The most recent call on file is dated September 16, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
CNC
Exchange
NYSE
Country
US
Sector
Health Care
Industry
Health Care Providers and Services
Calls on record
81
First call
January 13, 2020
Most recent
September 16, 2026
Reporting cadence
quarterly
Quarter Date
Company Conference Presentations Sep 16, 2026 Read transcript →
Earnings Calls Sep 11, 2026 Read transcript →
Q2 FY2026 Jul 28, 2026 Read transcript →
Q1 FY2026 Apr 28, 2026 Read transcript →
Special Calls Apr 17, 2026 Read transcript →
Earnings Calls Apr 13, 2026 Read transcript →
Company Conference Presentations Mar 10, 2026 Read transcript →
Q4 FY2025 Feb 6, 2026 Read transcript →
Company Conference Presentations Nov 11, 2025 Read transcript →
Q3 FY2025 Oct 29, 2025 Read transcript →
Special Calls Sep 16, 2025 Read transcript →
Company Conference Presentations Sep 11, 2025 Read transcript →
Q2 FY2025 Jul 25, 2025 Read transcript →
Q1 FY2025 Apr 25, 2025 Read transcript →
Special Calls Apr 17, 2025 Read transcript →
Company Conference Presentations Mar 12, 2025 Read transcript →
Q4 FY2024 Feb 4, 2025 Read transcript →
Analyst/Investor Day Dec 12, 2024 Read transcript →
Q3 FY2024 Oct 25, 2024 Read transcript →
Company Conference Presentations Sep 18, 2024 Read transcript →
Company Conference Presentations Sep 4, 2024 Read transcript →
Q2 FY2024 Jul 26, 2024 Read transcript →
Company Conference Presentations May 31, 2024 Read transcript →
Q1 FY2024 Apr 26, 2024 Read transcript →
Company Conference Presentations Mar 12, 2024 Read transcript →
Earnings Calls Feb 6, 2024 Read transcript →
Company Conference Presentations Jan 9, 2024 Read transcript →
Analyst/Investor Day Dec 12, 2023 Read transcript →
Q3 FY2023 Oct 24, 2023 Read transcript →
Company Conference Presentations Sep 13, 2023 Read transcript →
Company Conference Presentations Sep 6, 2023 Read transcript →
Q2 FY2023 Jul 28, 2023 Read transcript →
Company Conference Presentations Jun 1, 2023 Read transcript →
Q1 FY2023 Apr 25, 2023 Read transcript →
Company Conference Presentations Mar 14, 2023 Read transcript →
Q4 FY2022 Feb 7, 2023 Read transcript →
Company Conference Presentations Jan 9, 2023 Read transcript →
Analyst/Investor Day Dec 16, 2022 Read transcript →
Company Conference Presentations Nov 8, 2022 Read transcript →
Q3 FY2022 Oct 25, 2022 Read transcript →
Company Conference Presentations Sep 13, 2022 Read transcript →
Q2 FY2022 Jul 26, 2022 Read transcript →
Special Calls Jun 17, 2022 Read transcript →
Company Conference Presentations May 10, 2022 Read transcript →
Shareholder/Analyst Calls Apr 26, 2022 Read transcript →
Q1 FY2022 Apr 26, 2022 Read transcript →
Company Conference Presentations Mar 15, 2022 Read transcript →
Earnings Calls Feb 8, 2022 Read transcript →
Company Conference Presentations Jan 10, 2022 Read transcript →
Analyst/Investor Day Dec 10, 2021 Read transcript →
Company Conference Presentations Nov 17, 2021 Read transcript →
Company Conference Presentations Nov 10, 2021 Read transcript →
Company Conference Presentations Nov 3, 2021 Read transcript →
Q3 FY2021 Oct 26, 2021 Read transcript →
Company Conference Presentations Sep 13, 2021 Read transcript →
Q2 FY2021 Jul 27, 2021 Read transcript →
Analyst/Investor Day Jun 16, 2021 Read transcript →
Company Conference Presentations Jun 3, 2021 Read transcript →
Company Conference Presentations May 12, 2021 Read transcript →
Shareholder/Analyst Calls Apr 27, 2021 Read transcript →
Q1 FY2021 Apr 27, 2021 Read transcript →
Company Conference Presentations Mar 16, 2021 Read transcript →
Company Conference Presentations Mar 9, 2021 Read transcript →
Earnings Calls Feb 9, 2021 Read transcript →
Company Conference Presentations Jan 11, 2021 Read transcript →
M&A Calls Jan 4, 2021 Read transcript →
Analyst/Investor Day Dec 18, 2020 Read transcript →
Company Conference Presentations Nov 16, 2020 Read transcript →
Company Conference Presentations Nov 10, 2020 Read transcript →
Q3 FY2020 Oct 27, 2020 Read transcript →
Company Conference Presentations Sep 14, 2020 Read transcript →
Q2 FY2020 Jul 28, 2020 Read transcript →
Company Conference Presentations Jun 23, 2020 Read transcript →
Analyst/Investor Day Jun 12, 2020 Read transcript →
Company Conference Presentations May 13, 2020 Read transcript →
Shareholder/Analyst Calls Apr 28, 2020 Read transcript →
Q1 FY2020 Apr 28, 2020 Read transcript →
Company Conference Presentations Mar 10, 2020 Read transcript →
Guidance/Update Calls Mar 4, 2020 Read transcript →
Q4 FY2019 Feb 4, 2020 Read transcript →
Company Conference Presentations Jan 13, 2020 Read transcript →